Dogwood Therapeutics, Inc.
DWTX
$1.94
-$0.10-4.90%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -131.21% | -31.91% | 75.99% | -313.53% | 65.15% |
| Total Depreciation and Amortization | -0.60% | 1.20% | -4.05% | 0.00% | 1.76% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -100.00% |
| Total Other Non-Cash Items | 1,362.47% | 501.21% | -99.32% | 20,054.67% | -99.06% |
| Change in Net Operating Assets | 682.27% | -354.63% | -87.75% | 222.20% | -21.81% |
| Cash from Operations | 21.28% | -26.12% | -11.13% | 18.71% | 14.02% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -100.00% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -100.00% | 13,091.67% | -- | -- | -- |
| Repurchase of Common Stock | 100.00% | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -100.00% | 34,535.89% | -- | 100.00% | -101.63% |
| Foreign Exchange rate Adjustments | -570.00% | -137.04% | 181.82% | -132.67% | 741.67% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -153.97% | 286.09% | -9.95% | 20.79% | -253.70% |